• Profile
Close

Body mass index and insulin use as identifiers of high-cost patients with type 2 diabetes: A retrospective analysis of electronic health records linked to insurance claims data

Diabetes, Obesity and Metabolism Feb 21, 2019

Johnston SS, et al. - In this retrospective study that consisted of 13,026 overweight or obese patients with antihyperglycemic-treated type 2 diabetes, researchers investigated the link between body mass index (BMI) and insulin use with type 2 diabetes-related healthcare expenditures (T2D-HE). The analyzed de-identified electronic health records linked to insurance claims data. Via multivariable regressions, they evaluated 1-year follow-up T2D-HE as a function of BMI, insulin use, an interaction term between BMI and insulin use, and patient demographics. Baseline insulin use rates ranged from 19.7% in overweight candidates to 33.0% in obese class III (OCIII) patients. Both BMI and insulin use were jointly linked to 1-year follow-up T2D-HE, which monotonically ranged from $5,842 in overweight patients with no insulin to $17,700 OCIII insulin users. The investigators concluded that BMI and insulin may have clinical utility as simple stratifiers for identifying high-cost patients. Because OCIII insulin users incurred the greatest annual healthcare expenditures, they may be an ideal group for targeted interventions.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay